GlassScriptPhysician profile
Dana M Park
NPI 1215036165
$2,784.45
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $531 · 2021: $1,244 · 2022: $95.64 · 2024: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $133.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $437.74 | 2019-2021 | |
| Abbvie INC. | $418.34 | 2020-2022 | |
| Amgen INC. | $343.47 | 2019-2021 | |
| Astellas Pharma US INC | $261.82 | 2019-2021 | |
| Amarin Pharma, INC. | $208.89 | 2019-2021 | |
| Pfizer INC. | $151.21 | 2019-2021 | |
| Abbott Laboratories | $148.93 | 2022-2024 | Cardiomems |
| Glaxosmithkline, LLC. | $141.03 | 2019-2021 | |
| Novo Nordisk INC | $111.68 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $92.02 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $79.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.27 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $37.52 | 2021 | |
| Mylan Specialty L.P. | $36.52 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $30.57 | 2021 | |
| Allergan, INC. | $29.16 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.79 | 2021 | |
| Horizon Therapeutics Plc | $16.67 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.39 | 2021 | |
| Boston Scientific Corporation | $14.14 | 2019 | |
| Almatica Pharma LLC | $13.84 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.41 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $12.26 | 2020 | |
| Nestle Healthcare Nutrition INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.